Safe drugs: Myth or reality?


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Today, requirements on the safety and effectiveness of medications are growing worldwide, leading to increased costs of their development. However, this paper shows that xenobiotic preparations cannot but cause side effects; the growing number of preparations in the market, polypharmacy abuse, and self-treatment increase the number of adverse consequences, including fatal ones. Health hazards also lurk in interactions between drugs and dietary supplements because of the latter’s lower certification level, as well as in their treatment effects associated with the patient’s diet and lifestyle specifics. In order to avoid negative consequences of drug intake, it is necessary to develop a personalized approach to xenobiotic pharmacotherapy that would use the results of pharmacogenomics and pharmacometabolomics, as well as therapeutic drug monitoring with strict account for possible drug–drug interactions.

Sobre autores

A. Archakov

Orekhovich Research Institute of Biomedical Chemistry

Autor responsável pela correspondência
Email: inst@ibmc.msk.ru
Rússia, Moscow

O. Ipatova

Orekhovich Research Institute of Biomedical Chemistry

Email: inst@ibmc.msk.ru
Rússia, Moscow

A. Lisitsa

Orekhovich Research Institute of Biomedical Chemistry

Email: inst@ibmc.msk.ru
Rússia, Moscow

S. Moshkovskii

Orekhovich Research Institute of Biomedical Chemistry

Email: inst@ibmc.msk.ru
Rússia, Moscow

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Pleiades Publishing, Ltd., 2016